Events


  • PLEO-CMT Results 16 October 2018


    Pharnext hosted a conference call to discuss study data of Phase 3 trial of PXT3003 for the treatment of CMT1A

    Live webcast

     


  • NMD 2018 29-31 OCTOBER 2018


    Pharnext will attend the Neuromuscular Drug Development Summit on October 29-31, 2018 in Boston, US

    Read more

     


  • Neurowoche 2018 30 oct - 3 Nov 2018


    Pharnext will attend the 91th Congress of the Deutschen Gesellschaft für Neurologie on October 30 to November 3, 2018 in Berlin, Germany

    Read More